These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 25544875)

  • 1. Involvement of the TAGE-RAGE system in non-alcoholic steatohepatitis: Novel treatment strategies.
    Takeuchi M; Takino J; Sakasai-Sakai A; Takata T; Ueda T; Tsutsumi M; Hyogo H; Yamagishi S
    World J Hepatol; 2014 Dec; 6(12):880-93. PubMed ID: 25544875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of toxic AGEs (TAGE) may be a promising novel biomarker in development and progression of NASH.
    Takeuchi M; Sakasai-Sakai A; Takata T; Ueda T; Takino J; Tsutsumi M; Hyogo H; Yamagishi S
    Med Hypotheses; 2015 May; 84(5):490-3. PubMed ID: 25697114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Relevance of Toxic AGEs (TAGE) Cytotoxicity to NASH Pathogenesis: A Mini-Review.
    Sakasai-Sakai A; Takata T; Takino JI; Takeuchi M
    Nutrients; 2019 Feb; 11(2):. PubMed ID: 30813302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of Intracellular TAGE and the TAGE-RAGE-ROS Axis in the Onset and Progression of NAFLD/NASH.
    Sakasai-Sakai A; Takeda K; Takeuchi M
    Antioxidants (Basel); 2023 Mar; 12(3):. PubMed ID: 36978995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of the toxic advanced glycation end-products-receptor axis in nonalcoholic steatohepatitis-related hepatocellular carcinoma.
    Takino J; Nagamine K; Hori T; Sakasai-Sakai A; Takeuchi M
    World J Hepatol; 2015 Oct; 7(23):2459-69. PubMed ID: 26483867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of the toxic AGEs (TAGE)-RAGE system in the pathogenesis of diabetic vascular complications: a novel therapeutic strategy.
    Takeuchi M; Takino J; Yamagishi S
    Curr Drug Targets; 2010 Nov; 11(11):1468-82. PubMed ID: 20583971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular Toxic Advanced Glycation End-Products Promote the Production of Reactive Oxygen Species in HepG2 Cells.
    Sakasai-Sakai A; Takata T; Takeuchi M
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32660150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Levels of Toxic AGEs (TAGE) May Be a Promising Novel Biomarker for the Onset/Progression of Lifestyle-Related Diseases.
    Takeuchi M
    Diagnostics (Basel); 2016 Jun; 6(2):. PubMed ID: 27338481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular Toxic AGEs (TAGE) Triggers Numerous Types of Cell Damage.
    Takeuchi M; Sakasai-Sakai A; Takata T; Takino JI; Koriyama Y; Kikuchi C; Furukawa A; Nagamine K; Hori T; Matsunaga T
    Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33808036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Progression of Non-Alcoholic Fatty Liver Disease: The Role of Advanced Glycation End Products.
    Fernando DH; Forbes JM; Angus PW; Herath CB
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31614491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxic AGE (TAGE) Theory for the Pathophysiology of the Onset/Progression of NAFLD and ALD.
    Takeuchi M; Takino JI; Sakasai-Sakai A; Takata T; Tsutsumi M
    Nutrients; 2017 Jun; 9(6):. PubMed ID: 28632197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of Hepatic Stellate Cell Death by Toxic Advanced Glycation End-Products.
    Takino JI; Sato T; Nagamine K; Sakasai-Sakai A; Takeuchi M; Hori T
    Biol Pharm Bull; 2021; 44(1):112-117. PubMed ID: 33390537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease.
    Leung C; Herath CB; Jia Z; Andrikopoulos S; Brown BE; Davies MJ; Rivera LR; Furness JB; Forbes JM; Angus PW
    World J Gastroenterol; 2016 Sep; 22(35):8026-40. PubMed ID: 27672297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accumulation of Toxic Advanced Glycation End-Products Induces Cytotoxicity and Inflammation in Hepatocyte-Like Cells Differentiated from Human Induced Pluripotent Stem Cells.
    Kikuchi C; Sakasai-Sakai A; Okimura R; Tanaka H; Takata T; Takeuchi M; Matsunaga T
    Biol Pharm Bull; 2021; 44(10):1399-1402. PubMed ID: 34602548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of TAGE-RAGE System in the Pathogenesis of Diabetic Retinopathy.
    Takeuchi M; Takino J; Yamagishi S
    J Ophthalmol; 2010; 2010():170393. PubMed ID: 20652047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for Toxic Advanced Glycation End-Products Generated in the Normal Rat Liver.
    Takata T; Sakasai-Sakai A; Takino JI; Takeuchi M
    Nutrients; 2019 Jul; 11(7):. PubMed ID: 31315223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TAGE (toxic AGEs) theory in diabetic complications.
    Sato T; Iwaki M; Shimogaito N; Wu X; Yamagishi S; Takeuchi M
    Curr Mol Med; 2006 May; 6(3):351-8. PubMed ID: 16712480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms in the receptor for advanced glycation end-products (RAGE) gene and circulating RAGE levels as a susceptibility factor for non-alcoholic steatohepatitis (NASH).
    Mehta R; Shaw G; Masschelin P; Felix S; Otgonsuren M; Baranova A; Goodman Z; Younossi Z
    PLoS One; 2018; 13(6):e0199294. PubMed ID: 29928018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential of an Interorgan Network Mediated by Toxic Advanced Glycation End-Products in a Rat Model.
    Inoue S; Takata T; Nakazawa Y; Nakamura Y; Guo X; Yamada S; Ishigaki Y; Takeuchi M; Miyazawa K
    Nutrients; 2020 Dec; 13(1):. PubMed ID: 33383715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of intracellular toxic advanced glycation end-products (TAGE) on murine myoblast cell death.
    Takata T; Sakasai-Sakai A; Takeuchi M
    Diabetol Metab Syndr; 2020; 12():54. PubMed ID: 32684984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.